D. Firat and L. Stutzman, Fibrous dysplasia of the bone, The American Journal of Medicine, vol.44, issue.3, pp.421-429, 1968.
DOI : 10.1016/0002-9343(68)90112-5

R. Chapurlat, P. Delmas, D. Liens, and P. Meunier, Long-Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.41, issue.7, pp.1746-52, 1997.
DOI : 10.1359/jbmr.1997.12.10.1746

M. Kelly, B. Brillante, and M. Collins, Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions, Osteoporosis International, vol.343, issue.1, pp.57-63, 2008.
DOI : 10.1007/s00198-007-0425-x

M. Kelly, B. Brillante, H. Kushner, G. Robey, P. Collins et al., Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone, Bone, vol.37, issue.3, pp.388-394, 2005.
DOI : 10.1016/j.bone.2005.04.026

D. Liens, P. Delmas, and P. Meunier, Long-term effects of intravenous pamidronate in fibrous dysplasia of bone, The Lancet, vol.343, issue.8903, pp.953-957, 1994.
DOI : 10.1016/S0140-6736(94)90069-8

J. Jimenez-andrade, W. Mantyh, A. Bloom, K. Freeman, J. Ghilardi et al., The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain, Neurobiology of Aging, vol.33, issue.5, pp.921-932, 2010.
DOI : 10.1016/j.neurobiolaging.2010.08.008

J. Jimenez-andrade, W. Mantyh, A. Bloom, H. Xu, A. Ferng et al., A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: Therapeutic opportunity for treating skeletal pain, Bone, vol.46, issue.2, pp.523-529, 2011.
DOI : 10.1016/j.bone.2009.09.013

M. Zylka, F. Rice, and D. Anderson, Topographically Distinct Epidermal Nociceptive Circuits Revealed by Axonal Tracers Targeted to Mrgprd, Neuron, vol.45, issue.1, pp.17-25, 2005.
DOI : 10.1016/j.neuron.2004.12.015

P. Mantyh, Cancer pain and its impact on diagnosis, survival and quality of life, Nature Reviews Neuroscience, vol.5, issue.10, pp.797-809, 2006.
DOI : 10.1038/nrn1914

N. Lane, T. Schnitzer, C. Birbara, M. Mokhtarani, D. Shelton et al., Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee, New England Journal of Medicine, vol.363, issue.16, pp.1521-1531, 2010.
DOI : 10.1056/NEJMoa0901510

W. Mantyh, J. Jimenez-andrade, J. Stake, A. Bloom, M. Kaczmarska et al., Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain, Neuroscience, vol.171, issue.2, pp.588-598, 2010.
DOI : 10.1016/j.neuroscience.2010.08.056

K. Halvorson, K. Kubota, M. Sevcik, T. Lindsay, J. Sotillo et al., A Blocking Antibody to Nerve Growth Factor Attenuates Skeletal Pain Induced by Prostate Tumor Cells Growing in Bone, Cancer Research, vol.65, issue.20, pp.9426-9435, 2005.
DOI : 10.1158/0008-5472.CAN-05-0826

J. Jimenez-andrade, A. Bloom, J. Stake, W. Mantyh, R. Taylor et al., Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone Pain, Journal of Neuroscience, vol.30, issue.44, pp.14649-14656, 2010.
DOI : 10.1523/JNEUROSCI.3300-10.2010

S. Skaper, M. Pollock, and L. Facci, Mast cells differentially express and release active high molecular weight neurotrophins, Molecular Brain Research, vol.97, issue.2, pp.177-185, 2001.
DOI : 10.1016/S0169-328X(01)00314-X

P. Ehrhard, P. Erb, U. Graumann, and U. Otten, Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones., Proceedings of the National Academy of Sciences, vol.90, issue.23, pp.10984-10988, 1993.
DOI : 10.1073/pnas.90.23.10984

A. Freemont, A. Watkins, L. Maitre, C. Baird, P. Jeziorska et al., Nerve growth factor expression and innervation of the painful intervertebral disc, The Journal of Pathology, vol.8, issue.(2), pp.286-292, 2002.
DOI : 10.1002/path.1108

S. Ashraf, H. Wibberley, P. Mapp, R. Hill, D. Wilson et al., Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.523-529, 2011.
DOI : 10.1136/ard.2010.137844

S. Suri, S. Gill, M. De-camin, S. Wilson, D. Mcwilliams et al., Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis, Annals of the Rheumatic Diseases, vol.66, issue.11, pp.1423-1428, 2007.
DOI : 10.1136/ard.2006.063354

Z. Wu, K. Nagata, and T. Iijima, Involvement of sensory nerves and immune cells in osteophyte formation in the ankle joint of adjuvant arthritic rats, Histochem Cell Biol, vol.118, pp.213-220, 2002.

M. Collins, H. Kushner, J. Reynolds, C. Chebli, M. Kelly et al., An Instrument to Measure Skeletal Burden and Predict Functional Outcome in Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.38, issue.2, pp.219-226, 2005.
DOI : 10.1359/JBMR.041111

R. Daut, C. Cleeland, and R. Flanery, Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases, Pain, vol.17, issue.2, pp.197-210, 1983.
DOI : 10.1016/0304-3959(83)90143-4

R. Chapurlat, P. Hugueny, P. Delmas, and P. Meunier, Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment, Bone, vol.35, issue.1, pp.235-277, 2004.
DOI : 10.1016/j.bone.2004.03.004

R. Chapurlat and P. Meunier, The nonsurgical treatment of fibrous dysplasia, Rev Rhum Engl Ed, vol.66, issue.1, pp.1-3, 1999.

M. Parisi, B. Oliveri, and C. Mautalen, Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia, Bone, vol.33, issue.4, pp.582-590, 2003.
DOI : 10.1016/S8756-3282(03)00221-7

R. Weinstein, Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density, Journal of Bone and Mineral Research, vol.343, issue.8, pp.1314-1319, 1997.
DOI : 10.1359/jbmr.1997.12.8.1314

Y. Kitagawa, K. Tamai, and H. Ito, Oral alendronate treatment for polyostotic fibrous dysplasia: a case report, Journal of Orthopaedic Science, vol.9, issue.5, pp.521-526, 2004.
DOI : 10.1007/s00776-004-0809-0

J. Lane, S. Khan, O. Connor, W. Nydick, M. Hommen et al., Bisphosphonate Therapy in Fibrous Dysplasia, Clinical Orthopaedics and Related Research, vol.382, pp.6-12, 2001.
DOI : 10.1097/00003086-200101000-00003

R. Chapurlat, Medical Therapy in Adults With Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.20, issue.S2, pp.114-123, 2006.
DOI : 10.1359/jbmr.06s222

H. Plotkin, F. Rauch, L. Zeitlin, C. Munns, R. Travers et al., Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.10, pp.4569-75, 2003.
DOI : 10.1210/jc.2003-030050

R. Lala, P. Matarazzo, S. Bertelloni, F. Buzi, F. Rigon et al., Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome, Acta Paediatrica, vol.187, issue.2, pp.188-93, 2000.
DOI : 10.1111/j.1651-2227.2000.tb01214.x

G. Isaia, R. Lala, C. Defilippi, P. Matarazzo, M. Andreo et al., Bone Turnover in Children and Adolescents with McCune-Albright Syndrome Treated with Pamidronate for Bone Fibrous Dysplasia, Calcified Tissue International, vol.71, issue.2, pp.71121-71129, 2002.
DOI : 10.1007/s00223-001-1098-7

M. Zacharin, O. Sullivan, and M. , Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome, The Journal of Pediatrics, vol.137, issue.3, pp.403-412, 2000.
DOI : 10.1067/mpd.2000.107836

S. Kuznetsov, N. Cherman, M. Riminucci, M. Collins, G. Robey et al., Age-dependent demise of GNAS-mutated skeletal stem cells and " normalization " of fibrous dysplasia of bone, J Bone Miner Res, issue.11, pp.231741-231781, 2008.

T. Yamamoto, K. Ozono, S. Kasayama, K. Yoh, K. Hiroshima et al., Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome., Journal of Clinical Investigation, vol.98, issue.1, pp.30-35, 1996.
DOI : 10.1172/JCI118773

M. Riminucci, S. Kuznetsov, N. Cherman, A. Corsi, P. Bianco et al., Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression, Bone, vol.33, issue.3, pp.434-476, 2003.
DOI : 10.1016/S8756-3282(03)00064-4

P. Garnero, E. Mareau, E. Thompson, T. Woodworth, and J. Smolen, Rapid and sustained improvement in bone and cartilage turnover markers with the anti??????interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone, Arthritis & Rheumatism, vol.32, issue.1, pp.33-43, 2010.
DOI : 10.1002/art.25053